Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 22 results.
User Information
Export Records
  1. 1.   PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer
  2. Floudas, Charalampos S; Goswami, Meghali; Donahue, Renee N; Strauss, Julius; Pastor, Danielle M; Redman, Jason M; Brownell, Isaac; Turkbey, Evrim B; Steinberg, Seth M; Cordes, Lisa M; Marté, Jennifer L; Khan, Maheen H; McMahon, Sheri; Lamping, Elizabeth; Manu,Michell; Manukyan,Manuk; Brough, Douglas E; Lankford, Amy; Jochems, Caroline; Schlom, Jeffrey; Gulley, James L
  3. Cancer Immunology, Immunotherapy : CII. 2025, Mar 21; 74(5): 155.
  1. 2.   Near-infrared duocarmycin photorelease from a Treg-targeted antibody-drug conjugate improves efficacy of PD-1 blockade in syngeneic murine tumor models
  2. Fukushima, Hiroshi; Furusawa, Aki; Takao, Seiichiro; Thankarajan Mini Mablet,Ebaston; Luciano, Michael P; Usama, Syed Muhammad; Kano, Makoto; Okuyama, Shuhei; Yamamoto, Hiroshi; Suzuki, Motofumi; Kano, Miyu; Choyke, Peter L; Schnermann,Martin; Kobayashi, Hisataka
  3. Oncoimmunology. 2024, Jun 20; 13(1): 2370544.
  1. 3.   NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer
  2. Salomé, Bérengère; Sfakianos, John P; Ranti, Daniel; Daza, Jorge; Bieber, Christine; Charap, Andrew; Hammer, Christian; Banchereau, Romain; Farkas, Adam M; Ruan, Dan Fu; Izadmehr, Sudeh; Geanon, Daniel; Kelly, Geoffrey; de Real, Ronaldo M; Lee, Brian; Beaumont, Kristin G; Shroff, Sanjana; Wang, Yuanshuo A; Wang, Ying-Chih; Thin, Tin Htwe; Garcia-Barros, Monica; Hegewisch-Solloa, Everardo; Mace, Emily M; Wang, Li; O'Donnell, Timothy; Chowell, Diego; Fernandez-Rodriguez, Ruben; Skobe, Mihaela; Taylor, Nicole; Kim-Schulze, Seunghee; Sebra, Robert P; Palmer, Doug; Clancy-Thompson, Eleanor; Hammond, Scott; Kamphorst, Alice O; Malmberg, Karl-Johan; Marcenaro, Emanuela; Romero, Pedro; Brody, Rachel; Viard,Mathias; Yuki,Yuko; Martin,Pat; Carrington,Mary; Mehrazin, Reza; Wiklund, Peter; Mellman, Ira; Mariathasan, Sanjeev; Zhu, Jun; Galsky, Matthew D; Bhardwaj, Nina; Horowitz, Amir
  3. Cancer Cell. 2022, Sep 12; 40(9): 1027-1043.e9.
  1. 4.   Combination Methionine-methylation-axis Blockade: A Novel Approach to Target the Methionine Addiction of Cancer
  2. Higuchi, Takashi; Han, Qinghong; Sugisawa, Norihiko; Yamamoto, Jun; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Bouvet, Michael; Singh, Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M.
  3. Cancer Genomics Proteomics. 2021, Mar-Apr; 18(2): 113-120.
  1. 5.   Robust Expansion of HIV CAR T Cells Following Antigen Boosting in ART-Suppressed Nonhuman Primates
  2. Rust, Blake J; Kean, Leslie S; Colonna, Lucrezia; Brandenstein, Katherine; Poole, Nikhita Hegde; Obenza, Willimark; Enstrom, Mark R; Maldini, Colby R; Ellis, Gavin I; Fennessey,Christine; Huang, Meei-Li; Keele, Brandon F; Jerome, Keith; Riley, James L; Kiem, Hans-Peter; Peterson, Christopher William
  3. Blood. 2020, OCT 8; 136(15): 1722-1734.
  1. 6.   Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy
  2. Pérez-Guijarro, Eva; Yang, Howard H; Araya, Romina E; El Meskini,Rajaa; Michael, Helen T; Vodnala, Suman Kumar; Marie, Kerrie L; Smith,Cari; Chin, Sung; Lam, Khiem C; Thorkelsson, Andres; Iacovelli,Anthony; Kulaga,Alan; Fon, Anyen; Michalowski, Aleksandra M; Hugo, Willy; Lo, Roger S; Restifo, Nicholas P; Sharan,Shyam; Van Dyke, Terry; Goldszmid, Romina S; Ohler,Zoe; Lee, Maxwell P; Day, Chi-Ping; Merlino, Glenn
  3. Nature medicine. 2020, Apr 13;
  1. 7.   The outcome of TGFß antagonism in metastatic breast cancer models in vivo reflects a complex balance between tumor-suppressive and pro-progression activities of TGFß
  2. Yang, Yuan; Yang, Howard; Tang, Binwu; Wu, Alex Man Lai; Flanders, Kathleen C; Moshkovich, Nellie; Weinberg, Douglas S; Welsh, Michael A; Weng, Jia; Ochoa, Humberto J; Hu, Tiffany Y; Herrmann, Michelle A; Chen, Jinqiu; Edmondson,Elijah; Simpson, R Mark; Liu, Fang; Liu, Huaitian; Lee, Maxwell; Wakefield, Lalage M
  3. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020, FEB; 26(3): 643-656.
  1. 8.   A fully human anti-IL-7Ra antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia
  2. Akkapeddi, Padma; Fragoso, Rita; Hixon, Julie; Ramalho, Ana Sofia; Oliveira, Mariana L; Carvalho, Tânia; Gloger, Andreas; Matasci, Mattia; Corzana, Francisco; Durum, Scott; Neri, Dario; Bernardes, Gonçalo J L; Barata, João T
  3. Leukemia. 2019, SEP; 33(9): 2155-2168.
  1. 9.   Durvalumab in Combination with Olaparib in Patients with Relapsed Small Cell Lung Cancer: Results from a Phase II Study
  2. Thomas, Anish; Vilimas, Rasa; Trindade, Christopher; Erwin-Cohen,Rebecca; Roper, Nitin; Xi, Liqiang; Krishnasamy, Venkatesh; Levy, Elliot; Mammen, Andy; Nichols, Samantha; Chen, Yuanbin; Velcheti, Vamsidhar; Yin, Faye; Szabo, Eva; Pommier, Yves; Steinberg, Seth M; Trepel, Jane B; Raffeld, Mark; Young,Howard; Khan, Javed; Hewitt, Stephen; Lee, Jung-Min
  3. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2019, AUG; 14(8): 1447-1457.
  1. 10.   Report on the 2018 Cancer, Autoimmunity, and Immunology Conference
  2. Curran, Colleen S.; Sommers, Connie L.; Young,Howard; Bourcier, Katarzyna; Mancini, Marie; Sharon, Elad
  3. Journal of immunology (Baltimore, Md. : 1950). 2019, May 15; 202(10): 2823-2828.
  1. 11.   IFNL4-Delta G Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer
  2. Tang, Wei; Wallace, Tiffany A.; Yi, Ming; Magi-Galluzzi, Cristina; Dorsey, Tiffany H.; Onabajo, Olusegun O.; Obajemu, Adeola; Jordan, Symone V.; Loffredo, Christopher A.; Stephens, Bob; Silverman, Robert H.; Stark, George R.; Klein, Eric A.; Prokunina-Olsson, Ludmila; Ambs, Stefan
  3. CLINICAL CANCER RESEARCH. 2018, Nov 1; 24(21): 5471-5481.
  1. 12.   Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma
  2. Shankavaram, U. T.; Bredel, M.; Burgan, W. E.; Carter, D.; Tofilon, P.; Camphausen, K.
  3. Journal of Cellular and Molecular Medicine. 2012, Mar; 16(3): 545-554.
  1. 13.   Targeting the Activator Protein 1 Transcription Factor for the Prevention of Estrogen Receptor-Negative Mammary Tumors
  2. Shen, Q.; Uray, I. P.; Li, Y. X.; Zhang, Y.; Hill, J.; Xu, X. C.; Young, M. R.; Gunther, E. J.; Hilsenbeck, S. G.; Colburn, N. H.; Chodosh, L. A.; Brown, P. H.
  3. Cancer Prevention Research. 2008 1(1): 45-55.
  1. 14.   Upregulation of CTLA-4 by HIV-specific CD4(+) T cells correlates with disease progression and defines a reversible immune dysfunction
  2. Kaufmann, D. E.; Kavanagh, D. G.; Pereyra, F.; Zaunders, J. J.; Mackey, E. W.; Miura, T.; Palmer, S.; Brockman, M.; Rathod, A.; Piechocka-Trocha, A.; Baker, B.; Zhu, B.; Le Gall, S.; Waring, M. T.; Ahern, R.; Moss, K.; Kelleher, A. D.; Coffin, J. M.; Freeman, G. J.; Rosenberg, E. S.; Walker, B. D.
  3. Nature Immunology. 2007, Nov; 8(11): 1246-1254.
  1. 15.   Transcriptomic response to differentiation induction
  2. Patton, G. W.; Stephens, R.; Sidorov, I. A.; Xiao, X.; Lempicki, R. A.; Dimitrov, D. S.; Shoemaker, R. H.; Tudor, G.
  3. Bmc Bioinformatics. 2006, FEB 17; 7
  1. 16.   Novel human monoclonal antibodies to insulin-like growth factor (IGH)-II that potently inhibit the IGF receptor type I signal transduction function
  2. Feng, Y.; Zhu, Z. Y.; Xiao, X. D.; Choudhry, V.; Barrett, J. C.; Dimitrov, D. S.
  3. Molecular Cancer Therapeutics. 2006, JAN; 5(1): 114-120.
  1. 17.   AP-1 blockade in vivo suppresses development of mammary tumor in MMTV-erbB2 mice
  2. Shen, Q.; Kim, H. T.; Young, M.; Gunther, E.; Hilsenbeck, S.; Chodosh, L.; Colburn, N.; Brown, P.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, NOV; 14(11, Part 2 Suppl. S): 2692S-2692S.
  1. 18.   Provision of granulocyte-macrophage colony-stimulating factor converts an autoimmune response to a self-antigen into an antitumor response
  2. Ji, Q. Y.; Gondek, D.; Hurwitz, A. A.
  3. Journal of Immunology. 2005, AUG 1; 175(3): 1456-1463.
  1. 19.   Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection
  2. Thio, C. L.; Mosbruger, T. L.; Kaslow, R. A.; Karp, C. L.; Strathdee, S. A.; Vlahov, D.; O'Brien, S. J.; Astemborski, J.; Thomas, D. L.
  3. Journal of Virology. 2004, OCT; 78(20): 11258-11262.
  1. 20.   NK inhibitory-receptor blockade for purging of leukemia: Effects on hematopoietic reconstitution
  2. Koh, C. Y.; Raziuddin, A.; Welniak, L. A.; Blazar, B. R.; Bennett, M.; Murphy, W. J.
  3. Biology of Blood and Marrow Transplantation. 2002 8(1): 17-25.
  1. 21.   Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis
  2. Koyanagi, M.; Egashira, K.; Kitamoto, S.; Ni, W. H.; Shimokawa, H.; Takeya, M.; Yoshimura, T.; Takeshita, A.
  3. Circulation. 2000 102(18): 2243-2248.
  1. 22.   Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats
  2. Usui, M.; Egashira, K.; Tomita, H.; Koyanagi, M.; Katoh, M.; Shimokawa, H.; Takeya, M.; Yoshimura, T.; Matsushima, K.; Takeshita, A.
  3. Circulation. 2000 101(3): 305-310.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel